PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

Amgen Inc. (AMGN)

Equity · Currency in USD · Last updated Feb 24, 2024
SummaryFinancials

Company Info

ISINUS0311621009
CUSIP031162100
SectorHealthcare
IndustryDrug Manufacturers—General

Highlights

Market Cap$154.98B
EPS$12.49
PE Ratio23.15
PEG Ratio2.10
Revenue (TTM)$28.19B
Gross Profit (TTM)$19.92B
EBITDA (TTM)$12.23B
Year Range$206.75 - $327.16
Target Price$307.59
Short %1.74%
Short Ratio3.80

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM2023202220212020
Revenue

Total Revenue

28.19B28.19B26.32B25.98B25.42B

Cost Of Revenue

8.45B8.45B6.41B6.45B6.16B

Gross Profit

19.74B19.74B19.92B19.53B19.27B
Operating Expenses

Selling, General & Admin Expenses

6.18B5.48B5.41B5.37B5.73B

R&D Expenses

4.78B4.78B4.43B4.82B4.21B

Total Operating Expenses

11.84B11.84B10.35B10.38B10.13B
Income

Income Before Tax

7.86B7.86B7.35B6.70B8.13B

Operating Income

9.06B7.90B5.34B6.01B5.79B

EBIT

9.46B7.90B5.34B6.01B5.79B

Earnings From Continuing Operations

6.72B7.57B6.55B5.89B7.26B

Net Income

6.72B6.72B6.55B5.89B7.26B

Income Tax Expense

1.14B1.14B794.00M808.00M869.00M

Interest Expense

2.88B2.88B1.41B1.20B1.26B

Other Non-Operating Income (Expenses)

1.13B-42.00M2.01B696.00M2.34B

Extraordinary Items

0.000.000.000.000.00

Discontinued Operations

0.000.000.000.000.00

Effect Of Accounting Charges

0.000.000.000.000.00

Non Recurring

0.000.000.001.51B0.00

Minority Interest

0.000.000.000.000.00

Other Items

0.000.000.000.000.00
Values in USD except per share items